Skip to content

Evaluation of COVID-19 antigen test in COVID-19 suspected cases

Evaluation of COVID-19 antigen test in COVID-19 suspected cases - Evaluation of COVID-19 antigen test in COVID-19 suspected cases

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000040386
Enrollment
300
Registered
2020-07-01
Start date
2020-06-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Interventions

None listed

Sponsors

Nagasaki University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)COVID-19 suspected patient, 2)Patient who was performed genetic test, 3)Patient who was obtained blood sample

Exclusion criteria

Exclusion criteria: A patient who the attending doctor considered that a patient is not appropriate for the study.

Design outcomes

Primary

MeasureTime frame
Sensitivity, specificity, PPV, and NPV of COVID-19 antibody test in comparison with genetic test

Countries

Japan

Contacts

Public ContactNorihito Kaku

Nagasaki University Hospital Department of Laboratory Medicine

kaku-ngs@umin.ac.jp095-819-7574

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026